sNDA

Roche seeks new Lucentis indication

Roche seeks new Lucentis indication

By

The company is seeking a diabetic retinopathy indication.

Company news: Par Pharmaceutical; Gilead

By

Par Pharmaceutical is going private, selling to TPG for $1.9 billion in cash.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.